Cargando…
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407973/ https://www.ncbi.nlm.nih.gov/pubmed/36011210 http://dx.doi.org/10.3390/healthcare10081553 |
_version_ | 1784774493916364800 |
---|---|
author | Bortoletto, Riccardo Colizzi, Marco |
author_facet | Bortoletto, Riccardo Colizzi, Marco |
author_sort | Bortoletto, Riccardo |
collection | PubMed |
description | Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive epigenetic effects that can be intergenerationally inherited in brain areas which play a critical role in schizophrenia pathophysiology. Additionally, because of such cannabinoid-induced epigenetic effects, autism candidate genes present with bivalent chromatin markings which make them more vulnerable to subsequent disruption, possibly leading to psychosis onset later in life. Thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. However, such evidence has not received the attention it deserves. |
format | Online Article Text |
id | pubmed-9407973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94079732022-08-26 Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis Bortoletto, Riccardo Colizzi, Marco Healthcare (Basel) Viewpoint Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive epigenetic effects that can be intergenerationally inherited in brain areas which play a critical role in schizophrenia pathophysiology. Additionally, because of such cannabinoid-induced epigenetic effects, autism candidate genes present with bivalent chromatin markings which make them more vulnerable to subsequent disruption, possibly leading to psychosis onset later in life. Thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. However, such evidence has not received the attention it deserves. MDPI 2022-08-16 /pmc/articles/PMC9407973/ /pubmed/36011210 http://dx.doi.org/10.3390/healthcare10081553 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Viewpoint Bortoletto, Riccardo Colizzi, Marco Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis |
title | Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis |
title_full | Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis |
title_fullStr | Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis |
title_full_unstemmed | Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis |
title_short | Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis |
title_sort | cannabis use in autism: reasons for concern about risk for psychosis |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407973/ https://www.ncbi.nlm.nih.gov/pubmed/36011210 http://dx.doi.org/10.3390/healthcare10081553 |
work_keys_str_mv | AT bortolettoriccardo cannabisuseinautismreasonsforconcernaboutriskforpsychosis AT colizzimarco cannabisuseinautismreasonsforconcernaboutriskforpsychosis |